Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice

Neuroscience

Volumn 149, Issue 2, 2007, Pages 409-420

  Galeotti, N ^a   Quattrone, A ^a   Vivoli, E ^a   Bartolini, A ^a   Ghelardini, C ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

antinociception; intracellular Ca2+; muscarinic receptor; type 1 inositol 1,4,5 trisphosphate receptors; type 2 inositol 1,4,5 trisphosphate receptors; type 3 inositol 1,4,5 trisphosphate receptors

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; OXOTREMORINE; PHYSOSTIGMINE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; HOT PLATE TEST; LOCOMOTION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; EXPLORATORY BEHAVIOR; INJECTIONS, INTRAVENTRICULAR; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MALE; MEMBRANES; MICE; MOTOR ACTIVITY; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; MUSCULOSKELETAL EQUILIBRIUM; NOCICEPTORS; OLIGONUCLEOTIDES, ANTISENSE; OXOTREMORINE; PAIN MEASUREMENT; PHYSOSTIGMINE; RECEPTORS, MUSCARINIC; RNA, MESSENGER;

EID: 35348907272     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.07.049     Document Type: Article

References (32)

1. Aoki T., Narita M., Ohnishi O., Mizuo K., Narita M., Yajima Y., and Suzuki T. Disruption of the type 1 inositol 1,4,5-trisphosphate receptor gene suppresses the morphine-induced antinociception in the mouse. Neurosci Lett 350 (2003) 69-72
2. Ashkenazi A., Winslow J.W., Peralta E.G., Peterson G.L., Schimerlik M.I., Capon D.J., and Ramachandran J. An m2 muscarinic receptor subtype coupled to both adenylyl cyclase and phosphoinositide turnover. Science 238 (1987) 672-675
3. Bartolini A., Ghelardini C., Fantetti L., Malcangio M., Malmberg-Aiello P., and Giotti A. Role of muscarinic receptor subtypes in central antinociception. Br J Pharmacol 105 (1992) 77-82
4. Berridge M.J. Inositol trisphosphate and calcium signaling. Nature 361 (1993) 315-325
5. Berridge M.J. Neuronal calcium signaling. Neuron 21 (1998) 13-26
6. Caulfield M.P., and Birdsall N.J.M. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50 (1998) 279-290
7. Chen S.-R., Wess J., and Pan H.-L. Functional activity of the M2 and M4 receptor subtypes in the spinal cord studied with muscarinic acetylcholine receptor knockout mice. J Pharmacol Exp Ther 313 (2005) 765-770
8. Duttaroy A., Gomeza J., Gan J.-W., Siddiqui N., Basile A.S., Harman W.D., Smith P.L., Felder C.C., Levey A.I., and Wess J. Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice. Mol Pharmacol 62 (2002) 1084-1093
9. 3 pathway is involved in muscarinic antinociception. Neuropsychopharmacology 28 (2003) 888-897
10. 1 receptors. Br J Pharmacol 129 (2000) 1633-1640
11. 1 antagonist in vivo and in vitro. Life Sci 58 (1996) 991-1000
12. Gillberg P.G., Hartvig P., Gordh Jr. T., Sottile A., Jansson I., Archer T., and Post C. Behavioral effects after intrathecal administration of cholinergic receptor agonists in the rat. Psychopharmacology 100 (1990) 464-469
13. Gillbert P.G., Gordh Jr. T., Hartvig P., Jansson I., Petterson J., and Post C. Characterization of the antinociception induced by intrathecally administered carbachol. Pharmacol Toxicol 64 (1989) 340-343
14. 4 muscarinic receptor knockout mice. Life Sci 68 (2001) 2457-2466
15. Iwamoto E.T., and Marion L. Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats. J Pharmacol Exp Ther 266 (1993) 329-338
16. Matsumoto M., and Nagata E. Type 1 inositol 1,4,5-trisphosphate receptor knock-out mice: their phenotypes and their meaning in neuroscience and clinical practise. J Mol Med 77 (1999) 406-411
17. Matsumoto M., Nakagawa T., Inoue T., Nagata E., Tanaka K., Takano H., Minowa O., Kuno J., Sakakibara S., Yamada M., Yoneshima H., Miyawaki A., Fukuuchi Y., Furuichi T., Okano H., Mikoshiba K., and Noda T. Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor. Nature 379 (1996) 168-171
18. 2+ signaling. Curr Opin Neurobiol 7 (1997) 339-345
19. Minisclou C., Rouquier L., Benavides J., Scatton B., and Claustre Y. Muscarinic receptor-mediated increase in extracellular inositol 1,4,5-trisphosphate levels in the rat hippocampus: an in vivo microdyalysis study. J Neurochem 62 (1994) 557-562
20. Naguib M., and Yaksh T.L. Characterization of muscarinic receptor subtypes that mediate antinociception in the rat spinal cord. Anesth Analg 85 (1997) 847-853
21. 2+ wave trigger zone of the pancreatic acinar cells. J Biol Chem 269 (1994) 4693-4696
22. Ogura H., Matsumoto M., and Mikoshiba K. Motor discoordination in mutant mice heterozygous for the type 1 inositol 1,4,5-trisphosphate receptor. Behav Brain Res 122 (2001) 215-219
23. Patel S., Joseph S.K., and Thomas A.P. Molecular properties of inositol 1,4,5-trisphosphate receptors. Cell Calcium 25 (1999) 247-264
24. Ross C.A., Danoff S.K., Schell M.J., Snyder S.H., and Ullrich A. Three additional inositol 1,4,5-triphosphate receptors: molecular cloning and differential localization in rbrain and peripheral tissues. Proc Natl Acad Sci U S A 89 (1992) 4265-4269
25. Sharp A.H., Nucifora F.C., Blondel O., Sheppard C.A., Zhang C.Y., Snyder S.H., Russel J.T., Ryugo D.K., and Ross C.A. Differential cellular expression of isoforms of inositol 1,4,5-triphosphate receptors in neurons and glia in brain. J Comp Neurol 406 (1999) 207-220
26. 2+ waves in cultured astrocytes. J Neurochem 68 (1997) 2317-2327
27. 2+ release sites in oligodendrocyte processes. J Biol Chem 272 (1997) 22654-22661
28. Suguwara H., Kuro M., Takada M., and Kurosaki T. Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate receptors in signal transduction through the B-cell antigen receptor. EMBO J 16 (1997) 3078-3088
29. Taylor C.W., Genazzani A.A., and Morris S.A. Expression of inositol trisphosphate receptors. Cell Calcium 26 (1999) 237-251
30. Vaught J., Pelley K., Costa L.G., Sether P., and Enna S.J. A comparison of the antinociceptive responses to GABA-receptor agonists THIP and baclofen. Neuropharmacology 24 (1985) 211-216
31. Vermassen E., Parys J.B., and Mauger J.-P. Subcellular distribution of the inositol 1,4,5-trisphosphate receptors: functional relevance and molecular determinants. Biol Cell 96 (2004) 3-17
32. Yoon M.H., Choi J.I., and Jeong S.W. Antinociception of intrathecal cholinesterase inhibitors and cholinergic receptors in rats. Acta Anaesthesiol Scand 47 (2003) 1079-1108